While PD-L1 expression on tumor cells inhibits T-cell activation and proliferation, TGF-β signaling further suppresses immune responses by promoting regulatory T-cell differentiation, inhibiting effector T-cell function, and fostering an immunosuppressive milieu. This evidence concerns the gene TGFB1 and neoplasm.